...has found that there are 93 genes (including a further five previously unknown genes) in which a mutation could cause the development of breast cancer.
It is hoped that by analysing how these genes mutate into cancerous tissue will lead to gene profiling, which is capable of identifying the best treatments for patients diagnosed with breast cancer. Ultimately, this is a step towards personalised healthcare for treating cancer.
The development of patient pathways unique to each patient's genetic mutation is an exciting new development in the battle against cancer, and highlights the importance of gene discovery and analysis in developing new treatments, or enhancing the success rate for existing treatments, for cancer patients.